Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Entera Bio Ltd., a foreign private issuer, for the month of August 2021. The filing, dated August 23, 2021, incorporates by reference a press release issued on the same date. The registrant is headquartered in Jerusalem, Israel, and files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disseminate a press release and does not contain audited financial statements or specific financial data points.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. The document references an attached press release (Exhibit 99.1) but does not summarize its specific operational or financial content within the Form 6-K text provided.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. These details are contained within the incorporated press release, the text of which is not included in the provided input.
Key Facts for Investor Verification
- Verify the specific content of the press release dated August 23, 2021 (Exhibit 99.1), as the Form 6-K itself contains no operational details.
- Confirm the company's current cash runway and burn rate, as no financial metrics are disclosed in this specific filing.
- Review the company's Form 20-F for the most recent audited financial statements to assess liquidity and debt positions.
- Check for any subsequent filings that may supersede the information in this report.